What is Perfalytics, Inc d/b/a Freshpaint?
Freshpaint operates within the critical intersection of healthcare technology and data privacy. Its Healthcare Privacy Platform is designed to empower healthcare organizations to utilize industry-leading marketing and analytics tools without compromising adherence to stringent privacy mandates like HIPAA. This specialized offering addresses a significant market need for compliant data utilization, positioning Freshpaint as a key player in enabling secure digital engagement for healthcare providers and related entities.
How much funding has Perfalytics, Inc d/b/a Freshpaint raised?
Perfalytics, Inc d/b/a Freshpaint has raised a total of $45.2M across 3 funding rounds:
Series A
$9.5M
Debt
$5M
Series B
$30.7M
Series A (2022): $9.5M with participation from Intel Capital
Debt (2022): $5M led by Intel Capital
Series B (2024): $30.7M supported by Y Combinator, SignalFire, Intel Capital, and Zero Prime Ventures
Key Investors in Perfalytics, Inc d/b/a Freshpaint
Y Combinator
Y Combinator is a renowned startup accelerator that provides seed funding and mentorship to early-stage companies, playing a crucial role in nurturing emerging businesses across various sectors.
SignalFire
SignalFire is a venture capital firm that leverages data and AI to support early-stage teams, offering comprehensive services from portfolio support to strategic insights across technology sectors.
Intel Capital
Intel Capital is the venture capital investment arm of Intel, focusing on strategic investments in companies developing innovative technologies, including AI, cloud computing, and next-generation compute solutions.
What's next for Perfalytics, Inc d/b/a Freshpaint?
The substantial enterprise-level funding and recent strategic investment signal a robust growth trajectory for Freshpaint. This capital is likely to be deployed towards expanding its platform capabilities, enhancing its compliance features, and broadening its market reach within the healthcare industry. The company's focus on privacy-compliant data utilization positions it favorably to capitalize on the increasing demand for secure digital solutions in healthcare, suggesting a strategic push towards scaling operations and solidifying its market leadership.
See full Perfalytics, Inc d/b/a Freshpaint company page
